JPMorgan Chase & Co’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,067
| Closed | -$127K | – | 5724 |
|
|
2021
Q3 | $127K | Sell |
2,067
-922
| -31% | -$56.6K | ﹤0.01% | 4604 |
|
|
2021
Q2 | $233K | Sell |
2,989
-2,316
| -44% | -$181K | ﹤0.01% | 4414 |
|
|
2021
Q1 | $296K | Buy |
5,305
+851
| +19% | +$47.5K | ﹤0.01% | 4298 |
|
|
2020
Q4 | $273K | Buy |
4,454
+2,044
| +85% | +$125K | ﹤0.01% | 4048 |
|
|
2020
Q3 | $332K | Buy |
2,410
+2,034
| +541% | +$280K | ﹤0.01% | 3546 |
|
|
2020
Q2 | $44K | Sell |
376
-4
| -1% | -$468 | ﹤0.01% | 4249 |
|
|
2020
Q1 | $20K | Sell |
380
-45
| -11% | -$2.37K | ﹤0.01% | 4355 |
|
|
2019
Q4 | $23K | Buy |
425
+11
| +3% | +$595 | ﹤0.01% | 4405 |
|
|
2019
Q3 | $101K | Buy |
414
+44
| +12% | +$10.7K | ﹤0.01% | 3992 |
|
|
2019
Q2 | $83K | Buy |
+370
| New | +$83K | ﹤0.01% | 4083 |
|